insomnia
Conditions
Interventions
Dextrmetomidine group (group D):Use dexmedetomidine nasal spray before operation
Placebo group (group C):Preoperative use of saline nasal spray
Sponsors
The First Affiliated Hospital of Shihezi University Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-64 years; 2. Meet the diagnostic criteria of insomnia in the International Classification of Sleep Disorders Third edition (ICSD-3); 3. No recent symptoms of respiratory tract infection (within two weeks); 4. Able to cooperate with the evaluation of various scoring scales.
Exclusion criteria
Exclusion criteria: 1. Secondary insomnia caused by symptoms of physical disease or mental disorder; 2. Complicated with serious diseases of important organ functions (such as heart, brain, liver and kidney); 3. Patients who refuse or are allergic to dexmedetomidine; 4. Patients with a history of nasal diseases; 5. History of long-term use of hypnotic drugs (recent 1 month); 6. Pregnant and lactating patients; 7. Complicated sinus syndrome, severe bradycardia (<50 beats/min) or more than second degree atrioventricular block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep latency;Sleep staging;Sleep scale;Hemodynamic indexes; | — |
Countries
China
Contacts
Public ContactLi Yan
The First Affiliated Hospital of Shihezi University Medical College
Outcome results
None listed